Ripon College working with Eli Lilly to screen molecules for potential pharmaceutical use
Ripon College now is affiliated with the Open Innovation Drug Discovery Program at Eli Lilly. Through this program, students and faculty will use the technology at Eli Lilly to virtually screen molecules for their potential to be pharmaceuticals. After virtual screening, students and faculty will send molecules prepared at Ripon College to Eli Lilly for actual biological testing.
This program allows students and faculty to use their research to directly participate in the discovery of new pharmaceuticals. For example, several students in Assistant Professor of Chemistry Patrick Willoughby’s research lab have synthesized many completely new molecules. These molecules now can be assessed for their viability to treat disease and other ailments.
“I am excited to see student research at Ripon College directly contribute to the discovery of new drugs,” Willoughby says. “This undoubtedly will enhance their understanding of modern medicine and positively affect the prospect of them pursuing a career in health sciences.”
Related Posts
Halle Hadel ’25 and her dog, Eve, bring home Award of Merit from Westminster dog show
Halle Hadel ’25 of Ripon, Wisconsin, and her Siberian husky, Eve, received an Award of Merit earlier in May at the Westminster Kennel Club Dog […]
Review of exhibit featuring work of Rafael Francisco Salas published
A review of Professor of Art Rafael Francisco Salas’ recent exhibit was published May 9 on Shepard Express, a Milwaukee publication. “Cruces|Crossroads” was on view […]
Ripon College forms new chapter of Iota, Iota, Iota honor society
Ripon College has formed a new chapter of Iota Iota Iota (Triota), the national women’s and gender studies honor society. Initiation of the inaugural 17 […]
Farewell and thank you to our 2022-23 retirees
CINDY VIERTEL, 39 years Cindy Viertel will retire May 12, 2023. She came to Ripon in 1984 and was the hall director for Johnson Hall […]
